Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment?
作者信息
Costiniuk Cecilia T, Jenabian Mohammad-Ali
机构信息
Infectious Diseases and Immunity in Global Health, Research Institute of McGill University Health Centre, Montreal, QC, Canada; Division of Infectious Diseases/Chronic Viral Illness Service, McGill University Health Centre, Montreal, QC, Canada; Department of Microbiology & Immunology, McGill University, Montreal, QC, Canada.
Department of Microbiology & Immunology, McGill University, Montreal, QC, Canada; Department of Biological Sciences, Université du Québec à Montréal, Montreal, QC, Canada; Département de microbiologie, infectiologie et immunologie, Université de Montréal, Canada.
出版信息
Cytokine Growth Factor Rev. 2020 Jun;53:63-65. doi: 10.1016/j.cytogfr.2020.05.008. Epub 2020 May 20.
Abstract
摘要
相似文献
1
Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment?新型冠状病毒2感染的急性炎症与发病机制：大麻二酚能否作为一种潜在的抗炎治疗方法？
Cytokine Growth Factor Rev. 2020 Jun;53:63-65. doi: 10.1016/j.cytogfr.2020.05.008. Epub 2020 May 20.
2
Should we unstress SARS-CoV-2 infected cells?我们是否应该减轻感染了新冠病毒的细胞的应激反应？
Cytokine Growth Factor Rev. 2020 Aug;54:3-5. doi: 10.1016/j.cytogfr.2020.06.011. Epub 2020 Jun 11.
3
A critical evaluation of glucocorticoids in the management of severe COVID-19.糖皮质激素治疗重症 COVID-19 的评价。
Cytokine Growth Factor Rev. 2020 Aug;54:8-23. doi: 10.1016/j.cytogfr.2020.06.012. Epub 2020 Jun 24.
4
Treating COVID-19 with colchicine in community healthcare setting.在社区医疗环境中使用秋水仙碱治疗新冠病毒病
Clin Immunol. 2020 Aug;217:108490. doi: 10.1016/j.clim.2020.108490. Epub 2020 May 31.
5
Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19?没食子酸表没食子儿茶素（EGCG）在免疫失控性疾病中的保护作用：这种情况是否有助于对抗 COVID-19？
Int J Mol Sci. 2020 Jul 21;21(14):5171. doi: 10.3390/ijms21145171.
6
Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?-Lessons Learned From Cancer.β2-肾上腺素能通路能否成为抗击 SARS-CoV-2 炎症风暴综合征的新靶点？——癌症带来的启示。
Front Immunol. 2020 Sep 30;11:588724. doi: 10.3389/fimmu.2020.588724. eCollection 2020.
7
Leukoerythroblastosis and plasmacytoid lymphocytes in a child with SARS-CoV-2-associated multisystem inflammatory syndrome.一名患有新型冠状病毒2型相关多系统炎症综合征儿童的白细胞红细胞增多症和浆细胞样淋巴细胞
Blood. 2020 Aug 13;136(7):914. doi: 10.1182/blood.2020007132.
8
COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin.新型冠状病毒肺炎、肺肥大细胞、细胞因子风暴以及木犀草素的有益作用
Biofactors. 2020 May;46(3):306-308. doi: 10.1002/biof.1633. Epub 2020 Apr 27.
9
Dapsone and doxycycline could be potential treatment modalities for COVID-19.氨苯砜和强力霉素可能是治疗新冠肺炎的潜在方法。
Med Hypotheses. 2020 Jul;140:109768. doi: 10.1016/j.mehy.2020.109768. Epub 2020 Apr 22.
10
Successful use of methylprednisolone for treating severe COVID-19.甲基泼尼松龙成功用于治疗重症新型冠状病毒肺炎。
J Allergy Clin Immunol. 2020 Aug;146(2):325-327. doi: 10.1016/j.jaci.2020.05.021. Epub 2020 May 29.
引用本文的文献
1
Immunomodulatory effects of cannabinoids against viral infections: a review of its potential use in SARS-CoV2 infection.大麻素对病毒感染的免疫调节作用：对其在SARS-CoV2感染中潜在用途的综述
Virusdisease. 2024 Jun;35(2):342-356. doi: 10.1007/s13337-024-00871-0. Epub 2024 May 27.
2
Beta-Caryophyllene, a Cannabinoid Receptor Type 2 Selective Agonist, in Emotional and Cognitive Disorders.β-石竹烯，一种选择性大麻素受体 2 激动剂，在情绪和认知障碍中的作用。
Int J Mol Sci. 2024 Mar 11;25(6):3203. doi: 10.3390/ijms25063203.
3
Multi-targeting inulin-based nanoparticles with cannabidiol for effective prevention of ulcerative colitis.基于菊粉的多靶点纳米颗粒与大麻二酚用于有效预防溃疡性结肠炎
Mater Today Bio. 2024 Jan 19;25:100965. doi: 10.1016/j.mtbio.2024.100965. eCollection 2024 Apr.
4
Substances of abuse and their effect on SAR-CoV-2 pathogenesis.滥用物质及其对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）发病机制的影响。
NeuroImmune Pharm Ther. 2023 Jul 31;2(3):301-316. doi: 10.1515/nipt-2023-0004. eCollection 2023 Sep.
5
High-CBD cannabis extracts inhibit the expression of proinflammatory factors via miRNA-mediated silencing in human small intestinal epithelial cells.高CBD大麻提取物通过miRNA介导的沉默作用抑制人小肠上皮细胞中促炎因子的表达。
Heliyon. 2023 Aug 5;9(8):e18817. doi: 10.1016/j.heliyon.2023.e18817. eCollection 2023 Aug.
6
Tocilizumab-coated solid lipid nanoparticles loaded with cannabidiol as a novel drug delivery strategy for treating COVID-19: A review.载有大麻二酚的托珠单抗包覆固体脂质纳米粒作为治疗 COVID-19 的新型药物传递策略：综述。
Front Immunol. 2023 Mar 22;14:1147991. doi: 10.3389/fimmu.2023.1147991. eCollection 2023.
7
Therapeutic Effects of Cannabinoids and Their Applications in COVID-19 Treatment.大麻素的治疗作用及其在COVID-19治疗中的应用
Life (Basel). 2022 Dec 15;12(12):2117. doi: 10.3390/life12122117.
8
In the Swim of Cannabis: Developmental Toxicity and Metabolomic Pathway Alterations of Zebrafish Larvae Exposed to THC for the Assessment of Its Potential Environmental and Human Health Impact.在大麻的世界中畅游：暴露于 THC 的斑马鱼幼虫的发育毒性和代谢组学途径改变，用于评估其潜在的环境和人类健康影响。
Molecules. 2022 Aug 27;27(17):5506. doi: 10.3390/molecules27175506.
9
The Antimicrobial Properties of Cannabis and Cannabis-Derived Compounds and Relevance to CB2-Targeted Neurodegenerative Therapeutics.大麻及大麻衍生化合物的抗菌特性及其与靶向CB2的神经退行性疾病治疗的相关性。
Biomedicines. 2022 Aug 12;10(8):1959. doi: 10.3390/biomedicines10081959.
10
The Cross-Protective Immunity Landscape Among Different SARS-CoV-2 Variant RBDs.不同 SARS-CoV-2 变异株 RBD 间的交叉保护免疫全景。
Front Immunol. 2022 Jun 10;13:898520. doi: 10.3389/fimmu.2022.898520. eCollection 2022.
本文引用的文献
1
Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients.COVID-19 患者呼吸道中的先天免疫反应增强。
Cell Host Microbe. 2020 Jun 10;27(6):883-890.e2. doi: 10.1016/j.chom.2020.04.017. Epub 2020 May 4.
2
The many faces of the anti-COVID immune response.抗新冠病毒免疫反应的多面性。
J Exp Med. 2020 Jun 1;217(6). doi: 10.1084/jem.20200678.
3
Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility.在一家专业护理机构中出现的 SARS-CoV-2 感染前驱期和传播。
N Engl J Med. 2020 May 28;382(22):2081-2090. doi: 10.1056/NEJMoa2008457. Epub 2020 Apr 24.
4
Immune Responses Regulated by Cannabidiol.大麻二酚调节的免疫反应。
Cannabis Cannabinoid Res. 2020 Feb 27;5(1):12-31. doi: 10.1089/can.2018.0073. eCollection 2020 Mar 1.
5
Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure.COVID-19 患者严重呼吸衰竭的复杂免疫失调。
Cell Host Microbe. 2020 Jun 10;27(6):992-1000.e3. doi: 10.1016/j.chom.2020.04.009. Epub 2020 Apr 21.
6
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.在纽约市地区，5700 名因 COVID-19 住院的患者的特征、合并症和结局。
JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.
7
Macrophages: a Trojan horse in COVID-19?巨噬细胞：新冠病毒肺炎中的特洛伊木马？
Nat Rev Immunol. 2020 Jun;20(6):351. doi: 10.1038/s41577-020-0317-2.
8
COVID-19: immunopathology and its implications for therapy.新型冠状病毒肺炎：免疫病理学及其治疗意义。
Nat Rev Immunol. 2020 May;20(5):269-270. doi: 10.1038/s41577-020-0308-3.
9
Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19.SARS-CoV-2 和 SARS-CoV 在人肺中的比较复制和免疫激活特征：一项具有 COVID-19 发病机制意义的离体研究。
Clin Infect Dis. 2020 Sep 12;71(6):1400-1409. doi: 10.1093/cid/ciaa410.
10
Pathogenesis of COVID-19 from a cell biology perspective.从细胞生物学角度看 COVID-19 的发病机制。
Eur Respir J. 2020 Apr 16;55(4). doi: 10.1183/13993003.00607-2020. Print 2020 Apr.
Zotero 插件